Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122257734 | 12225773 | 4 | F | 2000 | 20160913 | 20160331 | 20160920 | EXP | US-PFIZER INC-2016183037 | PFIZER | 54.00 | YR | F | Y | 0.00000 | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122257734 | 12225773 | 1 | PS | CELEBREX | CELECOXIB | 1 | UNK | D | 20998 | CAPSULE, HARD | |||||||||
| 122257734 | 12225773 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, 1X/DAY | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||||
| 122257734 | 12225773 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||||
| 122257734 | 12225773 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 UG, 1X/DAY | 0 | 100 | UG | QD | ||||||||
| 122257734 | 12225773 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 122257734 | 12225773 | 6 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | UNK, AS NEEDED (BUTALBITAL: 50, CAFFEINE: 40, PARACETAMOL:325) | 0 | TABLET | ||||||||||
| 122257734 | 12225773 | 7 | C | CALAN | VERAPAMIL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122257734 | 12225773 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 122257734 | 12225773 | 9 | C | ATIVAN | LORAZEPAM | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 122257734 | 12225773 | 10 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | |||||||||
| 122257734 | 12225773 | 11 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122257734 | 12225773 | 2 | Fibromyalgia |
| 122257734 | 12225773 | 3 | Pain |
| 122257734 | 12225773 | 4 | Hypothyroidism |
| 122257734 | 12225773 | 6 | Migraine |
| 122257734 | 12225773 | 7 | Blood pressure measurement |
| 122257734 | 12225773 | 8 | Oedema |
| 122257734 | 12225773 | 9 | Anxiety |
| 122257734 | 12225773 | 10 | Diabetes mellitus |
| 122257734 | 12225773 | 11 | Myalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122257734 | 12225773 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122257734 | 12225773 | Dizziness | |
| 122257734 | 12225773 | Drug dependence | |
| 122257734 | 12225773 | Malaise | |
| 122257734 | 12225773 | Migraine | |
| 122257734 | 12225773 | Nausea | |
| 122257734 | 12225773 | Pain | |
| 122257734 | 12225773 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122257734 | 12225773 | 2 | 2000 | 0 | ||
| 122257734 | 12225773 | 4 | 1979 | 0 | ||
| 122257734 | 12225773 | 7 | 2005 | 0 | ||
| 122257734 | 12225773 | 9 | 2003 | 0 | ||
| 122257734 | 12225773 | 11 | 2008 | 0 |